Trials / Completed
CompletedNCT05163756
To Evaluate the Efficacy and Safety of DW1903 in Acute and Chronic Gastritis Patient
A Multi-center, Double-blind, Randomized, Parallel, Active-controlled, Non-inferiority, Phase III Clinical Trial to Evaluate the Efficacy and Safety of DW1903 in Patients With Gastritis
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 332 (actual)
- Sponsor
- Daewon Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 19 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
A Multi-center, Double-blind, Randomized, Parallel, Active-controlled, Non-inferiority, Phase III Clinical Trial to Evaluate the Efficacy and Safety of DW1903 in Patients with Gastritis
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DW1903 | q.d. PO, DW1903 + Placebo of DW1903-R1 |
| DRUG | DW1903-R1 | q.d. PO, Placebo of DW1903 + DW1903-R1 |
Timeline
- Start date
- 2020-11-25
- Primary completion
- 2021-04-27
- Completion
- 2021-05-10
- First posted
- 2021-12-20
- Last updated
- 2021-12-20
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05163756. Inclusion in this directory is not an endorsement.